secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2026-09-15T20:05:28+00:00
Accession:  0001493152-26-042744
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics signs MTA with ReadyGo to test sample prep tech on Co-Dx PCR platform
--------------------------------------------------------------------------------

- In August 2026, Co-Diagnostics entered a material transfer agreement with ReadyGo Diagnostics Ltd to evaluate ReadyGo's sample collection/preparation tech.
- Evaluation covers compatibility of ReadyGo's sample collection, lysis, stabilization, and prep technologies with Co-Dx PCR platform.
- ReadyGo will supply sampling materials for feasibility studies; no obligation for further development, supply, or commercialization.
- Co-Dx PCR platform and tests are not yet FDA-approved and are not currently available for sale.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226042744/0001493152-26-042744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226042744/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer